IDEAYA Biosciences (NASDAQ:IDYA) Price Target Increased to $68.00 by Analysts at Stifel Nicolaus
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price target boosted by Stifel Nicolaus from $63.00 to $68.00 in a research report report published on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. Several other research analysts have also commented on IDYA. Mizuho initiated coverage on shares of IDEAYA Biosciences […]
More Stories
America Votes: What to Expect
By Lawrence Wilson Democrats appear poised to win control of the House and possibly the Senate on Nov. 3 as...
One Canadian Confirmed Among 69 Victims of Fatal Spanish Train Crash
By Jennifer Cowen Global Affairs has confirmed one Canadian was killed in last week’s high-speed rail collision in Spain. Sixty-nine...
All of Us Are Dead Season 2: Recent Updates and Cast Members
After letting fans wait for almost 4 years, All of Us Are Dead is getting ready for the continuation of...
US Took Enforcement Action Against 2.2 Million Illegal Immigrants, Officials Say
By Jack Phillips U.S. immigration officials say that the second Trump administration has moved to terminate or revoke the status...
Why Did Emily Osment Request an Intimate Coordinator for Young Sheldon?
Emily Osment’s recently commented on her behind-the-scenes experience with co-star Montana Jordan during Young Sheldon’s shooting. It is making headlines...
GM Agrees to $220 Million Settlement Over Selling Driver Data
By Naveen Athrappully General Motors (GM) has agreed to a $220 million settlement with a coalition of 36 attorneys general...